Abstract
The effect of sulfur-containing benzimidazoles (thiabendazole, 5-hydroxy-thiabendazole, cambendazole) and sulfur-free derivatives (benzimidazole, carbendazim and 5-hydroxycarbendazim) on cytochrome P450 enzymes was investigated in primary cultures of rabbit hepatocytes considered 72 h after plating. Thiabendazole, cambendazole and carbendazim led to a significant dose-dependent increase in both EROD activity and cytochrome P4501A1/2 proteins and mRNA expression. Experiments using actinomycin D strongly suggest that these compounds have a transcriptional control on both CYP1A1 and CYP1A2 genes in primary hepatocytes. Thiabendazole increased both COH activity and P4502A protein levels. We conclude that sulfur is not a prerequisite to the P450 induction potential of benzimidazoles, while 5-hydroxylation leads to inefficient metabolites in terms of inducibility.
Citations
Apr 2, 1999·European Journal of Biochemistry·M BacklundM Ingelman-Sundberg
Jul 19, 2011·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·L RibonnetY Larondelle
Jun 24, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R J PriceB G Lake
Jun 10, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Rob StierumJohn Groten
Jul 15, 1997·Biochemical Pharmacology·S GradeletP Lesca
Aug 9, 2005·Bioorganic & Medicinal Chemistry·Anelia Ts MavrovaMitka K Micheva
Apr 28, 2004·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Roger J PriceBrian G Lake
Feb 12, 1998·The Journal of Biological Chemistry·M BacklundM Ingelman-Sundberg
May 23, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Silvia Diani-MooreArleen B Rifkind
Jul 5, 2003·The Journal of Pharmacy and Pharmacology·V BaliharováJ Fink-Gremmels
Apr 1, 1999·Human & Experimental Toxicology·H ShihL C Quattrochi
Aug 24, 2020·Ecotoxicology and Environmental Safety·Jesica Y GötteMirta L Menone
Feb 28, 2004·Life Sciences·G LemaireR Rahmani